Disease-Related Growth Factor and Embryonic Signaling Pathways Modulate an Enhancer of TCF21 Expression at the 6q23.2 Coronary Heart Disease Locus

PLoS Genetics

Volumn 9, Issue 7, 2013, Pages

  Miller, Clint L ^a   Anderson, D Ryan ^a   Kundu, Ramendra K ^a   Raiesdana, Azad ^a   Nürnberg, Sylvia T ^a   Diaz, Roxanne ^a   Cheng, Karen ^a   Leeper, Nicholas J ^a   Chen, Chung Hsing ^b   Chang, I Shou ^b   Schadt, Eric E ^c   Hsiung, Chao Agnes ^b   Assimes, Themistocles L ^a   Quertermous, Thomas ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CAPSULIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; WT1 PROTEIN;

ALLELE; ANIMAL CELL; AORTA; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 6Q; CHROMOSOME 6Q23; CONTROLLED STUDY; CORONARY ARTERY; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISCHEMIC HEART DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PYROSEQUENCING; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; TCF21 GENE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ALLELES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; CORONARY DISEASE; CORONARY VESSELS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; MYOCYTES, SMOOTH MUSCLE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; WILMS TUMOR;

EID: 84880779995     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003652     Document Type: Article

References (59)

1. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
2. Zhong H, Beaulaurier J, Lum PY, Molony C, Yang X, et al. (2010) Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet 6: e1000932.
3. Lu X, Wang L, Chen S, He L, Yang X, et al. (2012) Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet 44: 890-894.
4. Hidai H, Bardales R, Goodwin R, Quertermous T, Quertermous EE, (1998) Cloning of capsulin, a basic helix-loop-helix factor expressed in progenitor cells of the pericardium and the coronary arteries. Mech Dev 73: 33-43.
5. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, et al. (1999) The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126: 5771-5783.
6. Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, et al. (2012) The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139: 2139-2149.
7. Braitsch CM, Combs MD, Quaggin SE, Yutzey KE, (2012) Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart. Dev Biol 368: 345-357.
8. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. (2012) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45: 25-33.
9. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, et al. (2012) The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8: e1002793.
10. van Dam H, Castellazzi M, (2001) Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20: 2453-2464.
11. Karin M, Liu Z, Zandi E, (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246.
12. Raines EW, Ross R, (1993) Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69: S30-37.
13. Smith CL, Baek ST, Sung CY, Tallquist MD, (2011) Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circulation research 108: e15-26.
14. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP, (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33: 469-475.
15. Martinez-Estrada OM, Lettice LA, Essafi A, Guadix JA, Slight J, et al. (2010) Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet 42: 89-93.
16. White JT, Zhang B, Cerqueira DM, Tran U, Wessely O, (2010) Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus. Development 137: 1863-1873.
17. Nakagama H, Heinrich G, Pelletier J, Housman DE, (1995) Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 15: 1489-1498.
18. Gannon AM, Kinsella BT, (2009) The Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes. J Cell Mol Med 13: 4571-4586.
19. Laity JH, Dyson HJ, Wright PE, (2000) Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein. Proc Natl Acad Sci U S A 97: 11932-11935.
20. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, et al. (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17: 467-470.
21. Dejong V, Degeorges A, Filleur S, Ait-Si-Ali S, Mettouchi A, et al. (1999) The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun. Oncogene 18: 3143-3151.
22. McCoy C, McGee SB, Cornwell MM, (1999) The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ 10: 377-386.
23. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
24. Gonzalez-Navarro H, Abu Nabah YN, Vinue A, Andres-Manzano MJ, Collado M, et al. (2010) p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J Am Coll Cardiol 55: 2258-2268.
25. Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, et al. (2013) Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol 33: e1-e10.
26. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, et al. (2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 29: 1671-1677.
27. Quaggin SE, Vanden Heuvel GB, Igarashi P, (1998) Pod-1, a mesoderm-specific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney. Mech Dev 71: 37-48.
28. Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, et al. (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci U S A 103: 982-987.
29. Richards KL, Zhang B, Sun M, Dong W, Churchill J, et al. (2011) Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer 117: 606-617.
30. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, et al. (2010) From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466: 714-719.
31. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, et al. (2009) The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41: 885-890.
32. Cowper-Sal lari R, Zhang X, Wright JB, Bailey SD, Cole MD, et al. (2012) Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 44: 1191-1198.
33. Miano JM, Vlasic N, Tota RR, Stemerman MB, (1993) Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. Am J Pathol 142: 715-724.
34. Khachigian LM, Fahmy RG, Zhang G, Bobryshev YV, Kaniaros A, (2002) c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-Jun. J Biol Chem 277: 22985-22991.
35. Buganim Y, Madar S, Rais Y, Pomeraniec L, Harel E, et al. (2011) Transcriptional activity of ATF3 in the stromal compartment of tumors promotes cancer progression. Carcinogenesis 32: 1749-1757.
36. Lv D, Meng D, Zou FF, Fan L, Zhang P, et al. (2011) Activating transcription factor 3 regulates survivability and migration of vascular smooth muscle cells. IUBMB Life 63: 62-69.
37. Hai T, Curran T, (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A 88: 3720-3724.
38. Maouche S, Schunkert H, (2012) Strategies beyond genome-wide association studies for atherosclerosis. Arterioscler Thromb Vasc Biol 32: 170-181.
39. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, et al. (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43: 513-518.
40. Mellgren AM, Smith CL, Olsen GS, Eskiocak B, Zhou B, et al. (2008) Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circulation research 103: 1393-1401.
41. Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, et al. (2009) PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol 296: H442-452.
42. Mack CP, (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31: 1495-1505.
43. Armulik A, Abramsson A, Betsholtz C, (2005) Endothelial/pericyte interactions. Circulation research 97: 512-523.
44. Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A, (1999) YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126: 1845-1857.
45. Turnbull C, Perdeaux ER, Pernet D, Naranjo A, Renwick A, et al. (2012) A genome-wide association study identifies susceptibility loci for Wilms tumor. Nat Genet 44: 681-684.
46. Serluca FC, (2008) Development of the proepicardial organ in the zebrafish. Dev Biol 315: 18-27.
47. Wagner KD, Wagner N, Bondke A, Nafz B, Flemming B, et al. (2002) The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J 16: 1117-1119.
48. Dardik R, Loscalzo J, Eskaraev R, Inbal A, (2005) Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler Thromb Vasc Biol 25: 526-532.
49. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S, (2010) Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 31: 642-648.
50. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
51. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
52. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 41: 909-914.
53. Timofeeva MN, Hung RJ, Rafnar T, Christiani DC, Field JK, et al. (2012) Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet 21: 4980-4995.
54. Bu X, Quertermous T, (1997) Identification of an endothelial cell-specific regulatory region in the murine endothelin-1 gene. J Biol Chem 272: 32613-32622.
55. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, et al. (2007) Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4: 651-657.
56. Nurnberg ST, Rendon A, Smethurst PA, Paul DS, Voss K, et al. (2012) A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site. Blood 120: 4859-4868.
57. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.
58. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
59. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.